GLP-1 and Hormonal Secretion in Posttransplant DiabetesGLP-1 and Hormonal Secretion in Posttransplant Diabetes
The incretin hormone glucagon-like peptide 1 (GLP-1) appears to correct the abnormal secretion of insulin and glucagon in posttransplantation diabetes (PTDM), researchers from Norway and Denmark report. Reuters Health Information
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Diabetes & Endocrinology News Source Type: news
More News: Diabetes | Endocrinology | Health | Hormones | Incretin Therapy | Insulin | Transplant Surgery | Transplants